Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized double-blind placebo controlled trial which aims to evaluate the
efficacy and tolerability of minocycline and Omega-3 fatty acids for patients with ARMS.
Specifically to determine whether the addition of minocycline and / or Omega-3 fatty acids to
Treatment as Usual in an operationalized ARMS population in Pakistan:
Phase:
Phase 2
Details
Lead Sponsor:
Pakistan Institute of Learning and Living Pakistan Institute of Living and Learning